Enbrel 50 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FQQZY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,183
Award facts
- Contract value 100% obligated
- $19,183.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,183.16 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL syringes, effective June 2, 2025, with completion targeted for June 3, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 master contract vehicle extending through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical federal vendor for military and veteran healthcare systems through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company's delivery orders consistently involve firm fixed-price arrangements across a diverse therapeutic portfolio, ranging from specialty medications to brand-name and generic drugs. This particular award for Enbrel, a specialty rheumatoid arthritis medication, exemplifies AmerisourceBergen's capability to fulfill federal medical supply requirements for immunosuppressive biologics and other specialized pharmaceutical commodities supporting Defense Health Agency and other military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FQQZY?
SPE2DB25FQQZY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FQQZY worth?
The government has obligated $19,183 on SPE2DB25FQQZY.
Is contract SPE2DB25FQQZY an order under another contract?
Yes. SPE2DB25FQQZY is a delivery order under SPE2DB25D2207, an indefinite delivery contract.
Was contract SPE2DB25FQQZY competed?
The extent of competition for SPE2DB25FQQZY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award